Transaction in Own Shares

For immediate release

                                                                  30 April 2007

                  FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC                  

                                (the "Company")                                

                    MARKET PURCHASE OF COMPANY'S OWN SHARES                    

Notification is given, pursuant to the authority granted at the Annual General
Meeting of the Company held on 14 July 2006 to make market purchases of the
Company's own shares up to an aggregate maximum of 8,630,065, that a market
total of 31,000 Ordinary shares of 25p each in the capital of the Company were
purchased by the Company on 27 April 2007 at a price of 505.50p per share. Such
shares will be cancelled.

Following this transaction and in conformity with the Transparency Directive's
transitional provision 6 the Company hereby notifies the market that: the total
number of Ordinary shares held by the Company in treasury following the
purchase is 5,192,100; and the total number of Ordinary shares that the Company
has in issue, less the total number of Ordinary shares held by the Company in
treasury following such purchase, and therefore, the total number of voting
rights in the Company is 52,017,781.

The figure of 52,017,781 may be used by shareholders as the denominator for the
calculation by which they may determine if they are required to notify their
interest in, or change to their interest in, the Company under the FSA's
Disclosure and Transparency Rules.

For and on behalf of

Frostrow Capital LLP

Company Secretary

For further information, please contact:

Mark Pope

Frostrow Capital LLP

Tel: [phone]